2026 Global: Atherectomy Catheters Market -Competitive Review (2032) report
Description
The 2026 Global: Atherectomy Catheters Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Boston Scientific Corporation, headquartered in Marlborough, United States, is a dominant force in the Atherectomy Catheters Market, offering rotational and laser-assisted devices that support plaque modification during peripheral interventions. Medtronic plc, with its global headquarters in Dublin, Ireland, contributes a broad portfolio of vascular therapies that complement atherectomy strategies through integrated imaging and guidance systems. Terumo Corporation, based in Tokyo, Japan, supplies peripheral vascular catheters and adjunctive devices that align with atherectomy workflows, emphasizing procedural efficiency and safety. Philips Healthcare, headquartered in Amsterdam, Netherlands, pursues laser-assisted atherectomy through its Spectranetics business line, expanding options for laser-based debulking of calcified lesions. Collectively, these players drive regulatory adoption, clinical evidence, and payer acceptance, while supporting a continuum of care from lesion preparation to stenting. Their geographic breadth mirrors the global nature of cardiovascular disease and the demand for minimally invasive therapies with durable outcomes. Ongoing collaboration with researchers advances device design globally.
Cardiovascular Systems, Inc. (CSI), headquartered in St. Paul, United States, specializes in orbital and rotational atherectomy technologies such as the DiamondBack 360 system, targeting calcified lesions in peripheral and coronary arteries. Avinger, Inc., based in Santa Clara, United States, advances intravascular imaging integrated atherectomy with its proprietary catheter platforms designed for plaque modification and lesion crossing in complex lesions, often paired with endovascular visualization. AngioDynamics, headquartered in Latham, United States, offers endovascular devices including atherectomy catheters and adjunct therapies that extend access and deliverability in challenging anatomy, particularly for peripheral interventions. Together, these firms complement the larger portfolio players by emphasizing procedural ease, improved lesion preparation, and compatibility with imaging modalities. Market development is propelled by clinical data on deliverability, plaque modification, and optimization of stent expansion, reinforcing a multi-vendor landscape that broadens patient access to endovascular therapies across regions. Continued real-world evidence will shape device selection and guidelines globally.
Merit Medical Systems, headquartered in South Jordan, United States, serves vascular access and interventional therapy markets with a portfolio of devices that include atherectomy catheters, supporting plaque modification and lesion preparation in complex PAD cases. B. Braun Melsungen AG, based in Melsungen, Germany, contributes through its vascular intervention portfolio, emphasizing integration with surgical and radiological workflows, sterilization efficiencies, and distribution for peripheral devices including atherectomy-based solutions. Cordis, headquartered in Milpitas, United States, a Johnson & Johnson subsidiary, operates with a focus on peripheral vascular interventions and catheter-based therapies, leveraging its manufacturing and service network to support widespread adoption of atherectomy strategies paired with imaging and adjunctive devices. Collectively, these companies illustrate a tier ecosystem that balances large platforms with specialized device developers, shaping pricing, reimbursement, and training ecosystems across hospitals worldwide. Their ongoing product development and clinical collaborations inform guideline updates and reimbursement pathways for advanced endovascular plaque modification techniques.
Boston Scientific Corporation, headquartered in Marlborough, United States, is a dominant force in the Atherectomy Catheters Market, offering rotational and laser-assisted devices that support plaque modification during peripheral interventions. Medtronic plc, with its global headquarters in Dublin, Ireland, contributes a broad portfolio of vascular therapies that complement atherectomy strategies through integrated imaging and guidance systems. Terumo Corporation, based in Tokyo, Japan, supplies peripheral vascular catheters and adjunctive devices that align with atherectomy workflows, emphasizing procedural efficiency and safety. Philips Healthcare, headquartered in Amsterdam, Netherlands, pursues laser-assisted atherectomy through its Spectranetics business line, expanding options for laser-based debulking of calcified lesions. Collectively, these players drive regulatory adoption, clinical evidence, and payer acceptance, while supporting a continuum of care from lesion preparation to stenting. Their geographic breadth mirrors the global nature of cardiovascular disease and the demand for minimally invasive therapies with durable outcomes. Ongoing collaboration with researchers advances device design globally.
Cardiovascular Systems, Inc. (CSI), headquartered in St. Paul, United States, specializes in orbital and rotational atherectomy technologies such as the DiamondBack 360 system, targeting calcified lesions in peripheral and coronary arteries. Avinger, Inc., based in Santa Clara, United States, advances intravascular imaging integrated atherectomy with its proprietary catheter platforms designed for plaque modification and lesion crossing in complex lesions, often paired with endovascular visualization. AngioDynamics, headquartered in Latham, United States, offers endovascular devices including atherectomy catheters and adjunct therapies that extend access and deliverability in challenging anatomy, particularly for peripheral interventions. Together, these firms complement the larger portfolio players by emphasizing procedural ease, improved lesion preparation, and compatibility with imaging modalities. Market development is propelled by clinical data on deliverability, plaque modification, and optimization of stent expansion, reinforcing a multi-vendor landscape that broadens patient access to endovascular therapies across regions. Continued real-world evidence will shape device selection and guidelines globally.
Merit Medical Systems, headquartered in South Jordan, United States, serves vascular access and interventional therapy markets with a portfolio of devices that include atherectomy catheters, supporting plaque modification and lesion preparation in complex PAD cases. B. Braun Melsungen AG, based in Melsungen, Germany, contributes through its vascular intervention portfolio, emphasizing integration with surgical and radiological workflows, sterilization efficiencies, and distribution for peripheral devices including atherectomy-based solutions. Cordis, headquartered in Milpitas, United States, a Johnson & Johnson subsidiary, operates with a focus on peripheral vascular interventions and catheter-based therapies, leveraging its manufacturing and service network to support widespread adoption of atherectomy strategies paired with imaging and adjunctive devices. Collectively, these companies illustrate a tier ecosystem that balances large platforms with specialized device developers, shaping pricing, reimbursement, and training ecosystems across hospitals worldwide. Their ongoing product development and clinical collaborations inform guideline updates and reimbursement pathways for advanced endovascular plaque modification techniques.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
